Dr Jessica Gaevert

Dr Jessica Gaevert

Details

Role Research Officer

Contact

Dr. Jessica Gaevert is a postdoctoral researcher for Carolien van de Sandt within the Cellular Immunology Group in the Infection and Immunity and Global Health Theme at the Murdoch Children's Research Institute (MCRI).

Jessica completed her PhD in 2025 at the St. Jude Graduate School of Biomedical Sciences at St Jude Children's Research Hospital (United States) where she investigated cross-reactive CD8+ T cell receptors and how the cross-reactive repertoire changes across repeated influenza infections followed by one year of postdoctoral research.

In 2026 she relocated to MCRI to pursue postdoctoral research with Carolien van de Sandt focusing on T cell development and viral immunity across the human lifespan.
Dr. Jessica Gaevert is a postdoctoral researcher for Carolien van de Sandt within the Cellular Immunology Group in the Infection and Immunity and Global Health Theme at the Murdoch Children's Research Institute (MCRI).

Jessica completed her PhD in...
Dr. Jessica Gaevert is a postdoctoral researcher for Carolien van de Sandt within the Cellular Immunology Group in the Infection and Immunity and Global Health Theme at the Murdoch Children's Research Institute (MCRI).

Jessica completed her PhD in 2025 at the St. Jude Graduate School of Biomedical Sciences at St Jude Children's Research Hospital (United States) where she investigated cross-reactive CD8+ T cell receptors and how the cross-reactive repertoire changes across repeated influenza infections followed by one year of postdoctoral research.

In 2026 she relocated to MCRI to pursue postdoctoral research with Carolien van de Sandt focusing on T cell development and viral immunity across the human lifespan.

Top Publications

  • Wiggins, KB, Winston, SM, Reeves, IL, Gaevert, J, Spence, Y, Brimble, MA, Livingston, B, Morton, CL, Thomas, PG, Sant, AJ, et al. rAAV expressing a COBRA-designed influenza hemagglutinin generates a protective and durable adaptive immune response with a single dose.. J Virol 98(8) : e0078124 2024
    view publication
  • Gautam, A, Boyd, DF, Nikhar, S, Zhang, T, Siokas, I, Van de Velde, L-A, Gaevert, J, Meliopoulos, V, Thapa, B, Rodriguez, DA, et al. Necroptosis blockade prevents lung injury in severe influenza.. Nature 628(8009) : 835 -843 2024
    view publication
  • Luque Duque, D, Gaevert, JA, Thomas, PG, López-García, M, Lythe, G, Molina-París, C. Multi-variate model of T cell clonotype competition and homeostasis.. Sci Rep 13(1) : 21995 2023
    view publication
  • Mayer-Blackwell, K, Schattgen, S, Cohen-Lavi, L, Crawford, JC, Souquette, A, Gaevert, JA, Hertz, T, Thomas, PG, Bradley, P, Fiore-Gartland, A. TCR meta-clonotypes for biomarker discovery with tcrdist3 enabled identification of public, HLA-restricted clusters of SARS-CoV-2 TCRs.. Elife 10: 2021
    view publication
  • Gaevert, JA, Luque Duque, D, Lythe, G, Molina-París, C, Thomas, PG. Quantifying T Cell Cross-Reactivity: Influenza and Coronaviruses.. Viruses 13(9) : 2021
    view publication

Career information